Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details

About Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique is a journal published by Elsevier Masson s.r.l.. This journal covers the area[s] related to Oncology, Radiology, Nuclear Medicine and Imaging, etc. The coverage history of this journal is as follows: 1997-2022. The rank of this journal is 14214. This journal's impact score, h-index, and SJR are 1.24, 35, and 0.330, respectively. The ISSN of this journal is/are as follows: 12783218.

The best quartile of Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique is Q3. This journal has received a total of 451 citations during the last three years (Preceding 2022).

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique Impact Score 2022-2023

The latest impact score (IS) of the Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique is 1.24. It is computed in the year 2023 as per its definition and based on Scopus data. 1.24

It is increased by a factor of around 0.19, and the percentage change is 18.1% compared to the preceding year 2021, indicating a rising trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Prediction of Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique Impact Score 2023

Impact Score 2022 of Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique is 1.24. If a similar upward trend continues, IS may increase in 2023 as well.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique h-index

 

The h-index of Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique is 35. By definition of the h-index, this journal has at least 35 published articles with more than 35 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique ISSN

The International Standard Serial Number (ISSN) of Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique is/are as follows: 12783218.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique Ranking and SCImago Journal Rank (SJR)

The Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique is ranked 14214 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.330.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique Publisher

The publisher of Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique is Elsevier Masson s.r.l.. The publishing house of this journal is located in the France. Its coverage history is as follows: 1997-2022.

Call For Papers (CFPs)

Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).

Abbreviation

The International Organization for Standardization 4 (ISO 4) abbreviation of Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique is Cancer radiother. : j. Soc. fr. radiother. oncol.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Cancer radiother. : j. Soc. fr. radiother. oncol.') can be used for citing, indexing, abstraction, and referencing purposes.

How to publish in Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

If your area of research or discipline is related to Oncology, Radiology, Nuclear Medicine and Imaging, etc., please check the journal's official website to understand the complete publication process.

Acceptance Rate

There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

• Interest/demand of researchers/scientists for publishing in a specific journal/conference.
• The complexity of the peer review process and timeline.
• Time taken from draft submission to final publication.
• Number of submissions received and acceptance slots
• And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.

Credits and Sources

• Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
• Journal Impact Factor, https://clarivate.com/
• Issn.org, https://www.issn.org/
• Scopus, https://www.scopus.com/